Ingevity Valuation
Is NGVT * undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
3/6Valuation Score 3/6
Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of NGVT * when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: NGVT * (MX$1430) is trading below our estimate of fair value (MX$3391.08)
Significantly Below Fair Value: NGVT * is trading below fair value by more than 20%.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for NGVT *?
Other financial metrics that can be useful for relative valuation.
What is NGVT *'s n/a Ratio? | |
---|---|
n/a | 0x |
n/a | n/a |
Market Cap | US$1.96b |
Key Statistics | |
---|---|
Enterprise Value/Revenue | 2.1x |
Enterprise Value/EBITDA | 7.9x |
PEG Ratio | 0.6x |
Price to Earnings Ratio vs Peers
How does NGVT *'s PE Ratio compare to its peers?
Company | Forward PE | Estimated Growth | Market Cap |
---|---|---|---|
Peer Average | 10.8x | ||
CYDSASA A Cydsa. de | 5.6x | 16.0% | Mex$10.3b |
GCC * GCC. de | 11.5x | 1.9% | Mex$60.6b |
CMOCTEZ * Corporación Moctezuma. de | 10.3x | n/a | Mex$64.2b |
ICH B Industrias CH S. A. B. de C. V | 15.7x | n/a | Mex$75.4b |
NGVT * Ingevity | 9.7x | 15.3% | Mex$2.0b |
Price-To-Earnings vs Peers: NGVT * is expensive based on its Price-To-Earnings Ratio (9.7x) compared to the peer average (8.3x).
Price to Earnings Ratio vs Industry
How does NGVT *'s PE Ratio compare vs other companies in the Global Chemicals Industry?
Price-To-Earnings vs Industry: NGVT * is good value based on its Price-To-Earnings Ratio (9.7x) compared to the Global Chemicals industry average (21.2x).
Price to Earnings Ratio vs Fair Ratio
What is NGVT *'s PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
Fair Ratio | |
---|---|
Current PE Ratio | 9.7x |
Fair PE Ratio | n/a |
Price-To-Earnings vs Fair Ratio: Insufficient data to calculate NGVT *'s Price-To-Earnings Fair Ratio for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Analyst Forecast: Insufficient data to show price forecast.